Amiras, D. http://orcid.org/0000-0002-6144-0048
Hurkxkens, T. J. http://orcid.org/0000-0002-2085-1692
Figueroa, D. http://orcid.org/0000-0002-0177-9920
Pratt, P. J http://orcid.org/0000-0001-9340-4781
Pitrola, B.
Watura, C. http://orcid.org/0000-0002-5557-6344
Rostampour, S.
Shimshon, G. J. http://orcid.org/0000-0003-4964-5988
Hamady, M. http://orcid.org/0000-0002-7512-1056
Article History
Received: 14 September 2020
Revised: 18 March 2021
Accepted: 4 May 2021
First Online: 10 June 2021
Declarations
:
: The scientific guarantor of this publication is Dimitri Amiras.
: No complex statistical methods were necessary for this paper.
: Written informed consent was obtained from all subjects (patients) in this study.
: We did not seek Institutional Review Board approval since all human participation in the study was deemed to be of minimal risk and fulfilled in a non-clinical and non-invasive context under informed consent.
: Philip Pratt is Chief Scientific Officer and Dimitri Amiras is a clinical advisor at Medical iSight Corporation. The authors of this manuscript declare no other relationships with any companies, whose products or services may be related to the subject matter of the article.
: • Prospective• Experimental study• Performed at one institution